Biological and clinical effects of ozone. Has ozone therapy a future in medicine?

British Journal of Biomedical Science

Volumn 56, Issue 4, 1999, Pages 270-279

  Bocci, V ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

2,3 diphosphoglycerate; Antioxidants; Cytokines; Oxidative stress; Ozone; Reactive oxygen species

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ANTIOXIDANT; CYTOKINE; OZONE; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

HUMANS; JOINT DISEASES; OXIDANTS, PHOTOCHEMICAL; OZONE; VASCULAR DISEASES;

EID: 0033405369     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Viebahn R. The use of ozone in medicine, vol. 2. Heidelberg: Karl F Haug Publishers, 1994.
2. Bocci V. Ozone as a bioregulator. Pharmacology and toxicology of ozonetherapy today. J Biol Regul Homeost Agents 1996; 10:31-53.
3. Pryor WA. Mechanisms of radical formation from reactions of ozone with target molecules in the lung. Free Radical Biol Med 1994; 17:451-65.
4. Mattassi R. Ozonoterapia. Milano: Organizzazione Editoriale Medico Farmaceutica, 1985.
5. Siemsen C-H. Ozon-Anwendung bei akuten und chronischen Gelenkerkrankungen. In: Beck EG, Viebahn-Hänsler R, eds. Ozon-Handbuch. Grundlagen. Prävention. Therapie. Landsberg/Lech: Ecomed, 1995: V9.2 1-V9.2 14.
6. Payr E. Über Ozonbehandlung in der chirurgie. Münch med Wochenschr 1935; 82:220-91.
7. Aubourg P. Ozon in der chirurgie. Mem Acad Chir 1940; 65:1183-92.
8. Carpendale MT, Freeberg J, McLeod Griffiss J. Does ozone alleviate AIDS diarrhoea? J Clin Gastroenterol 1993; 17:142-5.
9. Knoch H-G, Klug W. Ozon-sauerstoff-therapie der proktitis. Med Welt 1990; 41:371-4.
10. Wehrli F, Steinbart H. Erfahrungen mit der haematogenen oxydations - therapie (HOT). Ars Medici 1954; 10:44-51.
11. Wolff HH. Das medizinische ozon. Theoretische grundlagen, therapeutische anwedungen. Heidelberg: Verlag für Medizin, 1979.
12. Miroshin SJ, Kontorshikova CN. The use of ozonetherapy technology in the treatment of modern war surgical trauma. In: The ozone in biology and medicine. 2nd All Russian Scientific-Practical Conference, September 6-8, 1995. Russian Association of Ozonetherapy, Reshetnikovskaya Street 2, Nizhni Novgorod, 603006 Russia. 1995:16.
13. Shaschova NM, Kachalina TS, Nevmjatullin AL. Application of ozonotherapy in complex treatment of inner female genital inflammatory diseases. In: International Ozone Association, ed. Proceedings: ozone in medicine, 12th World Congress of the International Ozone Association, 15-18 May 1995, Lille France. Tours: Instaprint SA, 1995:145-55.
14. Filippi A, Kirschner H. Ozoniertes wasser zur desinfektion und prophylaxe in der zahn-mund-kieferheilkunde. In: Beck EG, Viebahn-Hänsler R, eds. Ozon-handbuch. Grundlagen. Prävention. Therapie. Landsberg/Lech: Ecomed, 1995: V12.2 1-V12.2 12.
15. Wasser GH. Behandlung von Verletzungen mit ozoniertem wasser. In: Beck EG, Viebahn-Hänsler R, eds. Ozon-handbuch. Grundlagen. Prävention. Therapie. Landsberg/Lech: Ecomed, 1995: V7.4 1-V7.4 8.
16. Bulinin VI, Solod NV, Moshurov IP. The first experience of chronic abscesses and pleura emphyema treatment by the method of ozonization. In: The ozone in biology and medicine. 2nd All Russian Scientific-Practical Conference, September 6-8, 1995. Russian Association of Ozonetherapy, Reshetnikovskaya Street 2, Nizhni Novgorod, 603006 Russia. 1995:20.
17. Kudravcev BP, Miroshin SJ, Semyonov SV. The use of ozonized solutions in complex treatment of peritonitis. In: The ozone in biology and medicine. 2nd All Russian Scientific-Practical Conference, September 6-8, 1995, Russian Association of Ozonetherapy, Reshetnikovskaya Street 2, Nizhni Novgorod, 603006 Russia. Nizhni Novgorod: 1995:20.
18. Kasumjan SA, Lelyanov AD, Guseva ED, Alexeev BP. The ozonetherapy of the acute suppurative infection. In: The ozone in biology and medicine. 2nd All Russian Scientific-Practical Conference, September 6-8, 1995, Russian Association of Ozonetherapy, Reshetnikovskaya Street 2, Nizhni Novgorod, 603006 Russia. Nizhni Novgorod: 1995:16
19. Schultz S. The role of ozone/oxygen in clindamycin-associated enterocolitis in the Djungarian hamster (Phodopus sungorus sungorus). Lab Anim 1986; 20:41-8.
20. Rokitansky O, Rokitansky A, Steiner I, Trubel W, Viebahn R, Washüttl J. Die Ozontherapie bei peripheren, arteriellen durchblutungsstörungen: klinik, biochemische und blutgasanalytische Untersuchungen. In: Wassar. Berlin: Ozon-Weltkongress, 1981:53-75.
21. Werkmeister H. Dekubitalgeschwüre und die Behandlung mit der Ozon-Unterdruckbegasung. In: Beck EG, Viebahn-Hänsler R, eds. Ozon-handbuck. Grundlagen. Prävention. Therapie. Landsberg/Lech: Ecomed, 1995:V7.1 1-V7.1 22.
22. Hernàndez F, Menéndez S, Wong R. Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free Radical Biol Med 1995; 19:115-9.
23. Wasser GH. Zerebrale durchblutungsstörungen. In: Beck EG, Viebahn-Hänsler R, eds. Ozon-Handbuch. Grundlagen. Prävention. Therapie. Landsberg/Lech: Ecomed, 1995:V6.3 1-V6.3 12.
24. Cooke ED, Pockley AG, Tucker AT, Kirby JDT, Bolton AE. Treatment of severe Raynaud's syndrome by injection of autologous blood pretreated by heating, ozonation and exposure to ultraviolet light (H-O-U) therapy. Int Angiol 1997; 16:250-4.
25. Laitinen M, Mäkinen K, Manninen H et al. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther 1998; 9:1481-6.
26. Valacchi G, Bocci V. Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets. Mediat Inflamm 1999; 8:In press.
27. Kraft K, Stenkamp E, Sachinidis A, Seewald S, Vetter H. Effect of autohemotherapy with ozone on cardiovascular risk factors in patients with mild hypertension. Perfusion 1998; 11:216-9.
28. Berson EL, Remulla JFC, Rosner B, Sandberg MA, Weigel-DiFranco C. Evaluation of patients with retinitis pigmentosa receiving electric stimulation, ozonated blood, and ocular surgery in Cuba. Arch Ophthalmol 1996; 114:560-3.
29. Bulmer J, Bolton AE, Pockley AG. Effect of combined heat, ozonation and ultraviolet irradiation (VasoCare™) on heat shock protein expression by peripheral blood leukocyte populations. J Biol Regul Homeost Agents 1997; 11:104-10.
30. Marmer RH, Parks S. Ozone treatment in retinitis pigmentosa: effect on color perception and blood gases. Ann Ophthalmol 1998; 30.161-3.
31. Marmer RH, Parks S. Ozone treatment in retinitis pigmentosa: effect on photo stress and contrast sensitivity. Ann Ophthalmol 1998; 30:164-6.
32. Bocci V. A reasonable approach for the treatment of HIV infection in the early phase with ozonetherapy (autohemotherapy). How inflammatory cytokines may have a therapeutic role. Mediat Inflamm 1994; 3:315-21.
33. Bocci V. Ozonetherapy as a possible biological response modifier in cancer. Forsch Komplementärmed 1998; 5:54-60.
34. Garber GE, Cameron DW, Hawley-Foss N, Greenway D, Shannon ME. The use of ozone-treated blood in the therapy of HIV infection and immune disease: a pilot study of safety and efficacy. AIDS 1991; 5:981-4.
35. Bocci V, Venturi G, Catucci M, Valensin PE, Zazzi M. Lack of efficacy of ozonetherapy in HIV infection. Clin Microbiol Infect 1998; 4:667-9.
36. Sharma YK, León J, Raskin I, Davis KR. Ozone-induced responses in Arabidopsis thaliana: the role of salicyclic acid in the accumulation of defense-related transcripts and induced resistance. Proc Natl Acad Sci USA 1996; 93:5099-104.
37. Sandermann Jr H, Ernst D, Heller W, Langebartels C. Ozone: an abiotic elicitor of plant defence reactions. Trends Plant Sci 1998; 3:47-50.
38. Christman MF, Morgan RW, Jacobson FS, Ames BN. Positive control of a regulon for defenses against oxidative stress and some heat-shock proteins in Salmonella typhimurium. Cell 1985; 41:753-62.
39. Spitz DR, Dewey WC, Li GC. Hydrogen peroxide or heat shock induces resistance to hydrogen peroxide in Chinese hamster fibroblasts. J Cell Physiol 1987; 131:364-73.
40. Rahman I, Clerch LB, Massaro D. Rat lung antioxidant enzyme induction by ozone. Am J Physiol 1991; 260:L412-8.
41. León OS, Menéndez S, Merino N et al. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediat Inflamm 1998; 7:289-94.
42. Bocci V. Does ozone therapy normalize the cellular redox balance? Med Hypotheses 1996; 46:150-4.
43. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90:7915-22.
44. Bondy SC. The relation of oxidative stress and hyperexcitation to neurological disease. Proc Soc Exp Biol Med 1995; 208:337-45.
45. Spector A. Oxidative stress-induced cataract: mechanism of action. FASEB J 1995; 9:1173-82.
46. Gomez Moraleda MA. Ozone therapy in the functional recovery from diseases involving damage to central nervous system cells. In: International Ozone Association, ed. Proceedings: ozone in medicine. 12th World Congress of the International Ozone Association, 15-18 May 1995, Lille, France. Tours: Instaprint SA, 1995:111-23.
47. Bocci V. Die senile makulopathie und verwandte erkrankungen. In: Beck EG, Viebahn-Hänsler R, eds. Ozon-handbuch. Grundlagen. Prävention. Therapie. Landsberg: Ecomed, 1997:1-25.
48. Fabris G, Tommasini G, Lavaroni A et al. Percutaneous treatment of lumbar herniated disk. Riv Neuroradiol 1997; 10:523-32.
49. 3 nell'ernia discale lombare. In: Ceccherelli F, Ricciardi A, eds. Lombalgie e lombosciatalgie. Criteri di diagnosi e cura. Torino: Edizioni Libreria Cortina, 1998:367-77.
50. Bocci V. Ipotetici meccanismi di azione dell'ozono nel trattamento del conflitto discoradicolare. In: Ceccherelli F, Ricciardi A, eds. Lombalgie e lombosciatalgie. Criteri di diagnosi e cura. Torino: Edizioni Libreria Cortina, 1998:331-40.
51. Brayda-Bruno M, Cinnella P. Il trattamento dell'ernia discale con infiltrazioni di ossigeno-ozono in paravertebrale. In: Ceccherelli F, Ricciardi A, eds. Lombalgie e lombosciatalgie. Criteri di diagnosi e cura. Torino: Edizioni Libreria Cortina, 1998:361-5.
52. US Environmental Protection Agency. Air quality criteria for ozone and other photochemical oxidants. Environmental criteria and assessment office. Research Triangle Park, NC: US Environmental Protection Agency. Publication no. EPA-600/8-84-020aF, 1986.
53. Warren DL, Last JA. Synergistic interaction of ozone and respirable aerosols on rat lungs. III. Ozone and sulfuric acid aerosol. Toxicol Appl Pharmacol 1987; 88:203-16.
54. O'Neill CA, van der Vliet A, Hu M-L et al. Oxidation of biologic molecules by ozone: the effect of pH. J Lab Clin Med 1993; 122:497-505.
55. Cross CE, van der Vliet A, O'Neill CA, Louie S, Halliwell B. Oxidants, antioxidants and respiratory tract lining fluids. Environ Health Perspect 1994; 102:185-91.
56. Kelly FJ, Mudway IS. Sensitivity to ozone: could it be related to an individual's complement of antioxidants in lung epithelium lining fluid? Redox Report 1997; 3:199-206.
57. Heffner JE, Repine JE. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 1989; 140:531-54.
58. Goldstein BD, Balchum OJ. Effect of ozone on lipid peroxidation in the red blood cell. Proc Soc Exp Biol Med 1967; 126:356-9.
59. Freeman BA, Mudd JB. Reaction of ozone with sulfhydryls of human erythrocytes. Arch Biochem Biophys 1981; 208:212-20.
60. Pryor WA. How far does ozone penetrate into the pulmonary air/tissue boundary before it reacts? Free Radical Biol Med 1992; 12:83-8.
61. Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem 1994; 269:9397-400.
62. May JM, Qu Z-C, Whitesell RR, Cobb CE. Ascorbate recycling in human erythrocytes: role of GSH in reducing dehydroascorbate. Free Radical Biol Med 1996; 20:543-51.
63. van der Vliet A, O'Neill CA, Eiserich JP, Cross CE. Oxidative damage to extracellular fluids by ozone and possible protective effects of thiols. Arch Biochem Biophys 1995; 321:43-50.
64. Yu BP. Cellular defenses against damage from reactive oxygen species. Physiol Rev 1994; 74:139-62.
65. Galleano M, Puntarulo S. Role of antioxidants on the erythrocytes resistance to lipid peroxidation after acute iron overload in rats. Biochim Biophys Acta 1995; 1271:321-6.
66. Halliwell B. Antioxidants in human health and disease. Annu Rev Nutr 1996; 16:33-50.
67. Mendiratta S, Qu Z-C, May JM. Erythrocyte ascorbate recycling: antioxidant effects in blood. Free Radical Biol Med 1998; 24:789-97.
68. Ueno I, Hoshino M, Miura T, Shinriki N. Ozone exposure generates free radicals in the blood samples in vitro. Detection by the ESR spin-trapping technique. Free Radical Res 1998; 29:127-35.
69. Cross CE, Reznick AZ, Packer L, Davis PA, Suzuki YJ, Halliwell B. Oxidative damage to human plasma proteins by ozone. Free Radical Res Commun 1992; 15:347-52.
70. Bocci V. Determinants of erythrocyte ageing: a reappraisal. Br J Haematol 1981; 48:515-22.
71. Shinriki N, Suzuki T, Takama K et al. Susceptibilities of plasma antioxidants and erythrocyte constituents to low levels of ozone. Haematologia 1998; 29:229-39.
72. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993; 84:407-12.
73. Bocci V, Valacchi G, Corradeschi F, Fanetti G. Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and on interleukin-8 production. Mediat Inflamm 1998; 7:313-7.
74. Hu M-L. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994; 233:380-5.
75. Bocci V, Luzzi E, Corradeschi F et al. Studies on the biological effects of ozone: 4. Cytokine production and glutathione levels in human erythrocytes. J Biol Regul Homeost Agents 1993; 7:133-8.
76. Bocci V, Paulesu L. Studies on the biological effects of ozone. 1. Induction of interferon gamma on human leucocytes. Haematologica 1990; 75:510-5.
77. Paulesu L, Luzzi E, Bocci V. Studies on the biological effects of ozone: 2. Induction of tumor necrosis factor (TNF-α) on human leucocytes. Lymphokine Cytokine Res 1991; 10:409-12.
78. Bocci V, Luzzi E, Corradeschi F, Paulesu L, Di Stefano A. Studies on the biological effects of ozone: 3. An attempt to define conditions for optimal induction of cytokines. Lymphokine Cytokine Res 1993; 12:121-6.
79. Bocci V, Valacchi G, Corradeschi F et al. Studies on the biological effects of ozone: 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone. J Biol Regul Homeost Agents 1998; 12:67-75.
80. Halliwell B. Free radicals and antioxidants: a personal view. Nutr Rev 1994; 53:253-65.
81. Jacobs M-T. Untersuchung uber zwischenfalle und typische komplikationen in der ozon-sauerstoff-therapie. Ozo Nachrichten 1982; 1:5.
82. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991; 10:2247-58.
83. Los M, Dröge W, Stricker K, Baeuerle PA, Schulze-Osthoff K. Hydrogen peroxide as a potent activator of T-lymphocyte functions. Eur J Immunol 1995; 25:159-65.
84. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radical Biol Med 1997; 22:269-85.
85. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986; 46:705-16.
86. Rice-Evans C, Miller NJ. Total antioxidant status in plasma and body fluids. In: Methods in enzymology. New York: Academic Press, Inc, 1994:279-93.
87. Pryor WA, Squadrito GL, Friedman M. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radical Biol Med 1995; 19:935-41.
88. Morrow JD, Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997; 36:1-21.
89. Del Corso A, Dal Monte M, Vilardo PG et al. Site-specific inactivation of aldose reductase by 4-hydroxynonenal. Arch Biochem Biophys 1998; 350:245-8.
90. Leonarduzzi G, Scavazza A, Biasi F et al. The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor β1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J 1997; 11:851-7.
91. Dianzani MU. 4-Hydroxynonenal and cell signalling. Free Radical Ret 1998; 28:553-60.
92. Serhan CN, Haeggström JZ, Leslie CC. Lipid mediator networks in cell signalling: update and impact of cytokines. FASEB J 1996; 10:1147-58.
93. Schwarz KB. Oxidative stress during viral infection: a review. Free Radical Biol Med 1996; 21:641-9.
94. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995; 358:1-3.
95. Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 1996; 36:83-106.
96. Bocci V, Luzzi E, Corradeschi F, Paulesu L. Studies on the biological effects of ozone: 5. Evaluation of immunological parameters and tolerability in normal volunteers receiving ambulatory autohaemotherapy. Biotherapy 1994; 7:83-90.
97. Bocci V, Luzzi E, Corradeschi F, Silvestri S. Studies on the biological effects of ozone: 6. Production of transforming growth factor b1 by human blood after ozone treatment. J Biol Regul Homeost Agents 1994; 8:108-12.
98. Martin P. Wound healing - aiming for perfect skin regeneration. Science 1997; 276:75-81.
99. Levine M, Conry-Cantilena C, Wang Y et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 1996; 93:3704-9.
100. Bocci V. Autohaemotherapy after treatment of blood with ozone. A reappraisal. J Int Med Res 1994; 22:131-44.
101. Bocci V. Ozone: a mixed blessing. New mechanisms of the action of ozone on blood cells make ozonated major autohaemotherapy (MAH) a rational approach. Forsch Komplementärmed 1996; 3:25-33.